Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP949538.RAASxvPMyme6FYmyW2v1fP0CePS-igGbt2ZGl1Nmjpe8w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP949538.RAASxvPMyme6FYmyW2v1fP0CePS-igGbt2ZGl1Nmjpe8w130_assertion type Assertion NP949538.RAASxvPMyme6FYmyW2v1fP0CePS-igGbt2ZGl1Nmjpe8w130_head.
- NP949538.RAASxvPMyme6FYmyW2v1fP0CePS-igGbt2ZGl1Nmjpe8w130_assertion description "[Their levels fell further with increasing tumour's stage and were higher in tumours from patients who remained disease free compared with those who developed local recurrence or distant metastasis or died from breast cancer.TRF2 showed a trend similar to that of TANK2 and POT1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949538.RAASxvPMyme6FYmyW2v1fP0CePS-igGbt2ZGl1Nmjpe8w130_provenance.
- NP949538.RAASxvPMyme6FYmyW2v1fP0CePS-igGbt2ZGl1Nmjpe8w130_assertion evidence source_evidence_literature NP949538.RAASxvPMyme6FYmyW2v1fP0CePS-igGbt2ZGl1Nmjpe8w130_provenance.
- NP949538.RAASxvPMyme6FYmyW2v1fP0CePS-igGbt2ZGl1Nmjpe8w130_assertion SIO_000772 17616810 NP949538.RAASxvPMyme6FYmyW2v1fP0CePS-igGbt2ZGl1Nmjpe8w130_provenance.
- NP949538.RAASxvPMyme6FYmyW2v1fP0CePS-igGbt2ZGl1Nmjpe8w130_assertion wasDerivedFrom befree-20150227 NP949538.RAASxvPMyme6FYmyW2v1fP0CePS-igGbt2ZGl1Nmjpe8w130_provenance.
- NP949538.RAASxvPMyme6FYmyW2v1fP0CePS-igGbt2ZGl1Nmjpe8w130_assertion wasGeneratedBy ECO_0000203 NP949538.RAASxvPMyme6FYmyW2v1fP0CePS-igGbt2ZGl1Nmjpe8w130_provenance.